Found 117 matching trials
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
PHASE2This phase II trial examines the use of blood-based biomarkers is to help i...
Location
Mayo Clinic in Arizona
Modified Barium Swallow in Measuring Swallowing Function After Surgery in Patients With Oropharyngeal Cancer
NAThis pilot clinical trial studies the modified barium swallow in measuring ...
Location
Multiple Locations
Symptoms and Quality of Life in Patients With Heterotopic Gastric Mucosa (HGM)
N/AThe goal of this observational study is to learn whether heterotopic gastri...
Location
Knappschaftskrankenhaus Bottrop
Patient-Reported Symptom Care Versus Usual Care After Esophageal Cancer Surgery: A Single-Center Phase 3 Randomized Trial
PHASE3Symptom management is fundamental to clinical care, and symptom monitoring ...
Location
Multiple Locations
Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis
N/AThe purpose of this study is the validation of a newly developed self-repor...
Natural History Study for Patients With Nemaline Myopathy in the UK
N/AThe goal of this study is to to learn more about what assessments would be ...
Status
Active Not Recruiting
Location
Department of Paediatric Neurology - Neuromuscular Service, Evelina Children's Hospital
Impact of Total Thyroidectomy on Voice and Swallowing
N/APurpose of this study is to evaluate the outcome of total thyroidectomy on ...
Location
University Hospital of Larissa
Evaluation of the Functional Status of Jejunoplasty and Coloplasty and Its Impact on Quality of Life (CEREC)
N/AThe goal of this prospective population-based cohort study is to assess:
*...
Location
Hospital Uversitari de Bellvitge
The Incidence of Aphasia, Dysarthria and Dysphagia Following Stroke
N/AThe objective of the study is to estimate the incidence and recovery of aph...
Location
University Hospital, department of neurology
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis
PHASE1Background:
GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Location
National Institutes of Health Clinical Center